Indo Us Biotech Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indo Us Biotech Limited has submitted a regulatory certificate from its Registrar and Share Transfer Agent, Bigshare Services Private Limited, confirming compliance with SEBI's dematerialization norms for the quarter ending 31 March 2026. The RTA confirms that no securities were received for dematerialization during the period from 31 December 2025 to 31 March 2026. As a result, no share certificates were mutilated, cancelled, or had any name substitutions in the register of members. This is a standard compliance filing required under SEBI regulations and does not indicate any unusual share transfer activity.
No material impact on shareholders or stock price. This is a routine regulatory confirmation of nil dematerialization activity, indicating normal operations of the company's share registry.